11 Patents
- US125655022026Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3′-ones as Cyclin-dependent Kinase Inhibitors
Pharmacosmos Holding A/S
0 cites - US125344722026Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
Pharmacosmos Holding A/S
0 cites - US124974042025Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
Pharmacosmos Holding A/S
0 cites - US124798552025Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
Pharmacosmos Holding A/S
0 cites - 0 cites
- US123123602025Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as Cyclin-dependent Kinase Inhibitors
Pharmacosmos Holding A/S
0 cites - US122854312025Treatment of Rb-negative Tumors Using Topoisomerase Inhibitors in Combination with Cyclin Dependent Kinase 4/6 Inhibitors
Pharmacosmos Holding A/S
0 cites - 0 cites
- 0 cites
- US116541482023Hspc-sparing Treatments for Rb-positive Abnormal Cellular Proliferation
G1 Therapeutics, Inc.
0 cites - US116434162023Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as Cyclin-dependent Kinase Inhibitors
G1 Therapeutics, Inc.
0 cites